| 氨基末端B型利钠肽前体与心房颤动的研究进展 |
| |
| 引用本文： | 韦哲,钟国强. 氨基末端B型利钠肽前体与心房颤动的研究进展[J]. 心血管病学进展, 2010, 31(1): 120-122. DOI: 10.3969/j.issn.1004-3934.2010.01.037 |
| |
| 作者姓名： | 韦哲 钟国强 |
| |
| 作者单位： | 广西医科大学第一附属医院心内科,广西,南宁,530021 |
| |
| 摘 要： | 目前氨基末端B型利钠肽前体正广泛应用于临床试验和心血管研究中,近年的研究显示心房颤动与氨基末端B型利钠肽前体水平升高有关。现主要就近年来关于氨基末端B型利钠肽前体作为危险因子和预测因素在心房颤动治疗方面的研究进展进行综述。
|
| 关 键 词： | 心房颤动 氨基末端B型利钠肽前体 |
Progress in Use of N-terminal pro-B-type Natriuretic Peptide for Atrial Fibrillation |
| |
| WEI Zhe,ZHONG Guo-qiang. Progress in Use of N-terminal pro-B-type Natriuretic Peptide for Atrial Fibrillation[J]. Advances in Cardiovascular Diseases, 2010, 31(1): 120-122. DOI: 10.3969/j.issn.1004-3934.2010.01.037 |
| |
| Authors: | WEI Zhe ZHONG Guo-qiang |
| |
| Affiliation: | WEI Zhe,ZHONG Guo-qiang(Department of Cardiology,The First Affiliated Hospital of Guangxi Medical University,Nanning 530021,China) |
| |
| Abstract: | N-terminal pro-B-type natriuretic is now widely used in clinical practice and cardiovascular research around the world. Research shows that atrial fibrillation was independently associated with increased levels of NT-proBNP. This article reviews the clinical utility of the level of NT-proBNP as an integrating marker of various risk factors,and as an incremental predictive marker for the treatment of atrial fibrillation. |
| |
| Keywords: | atrial fibrillation N-terminal pro-B-type natriuretic peptide |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
